Related Experiment Video
Updated: Oct 1, 2025

04:00
Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
Published on: July 26, 2024
723
Similarities, differences and overlaps between frailty and Parkinson's disease
Junya Ebina1, Satoru Ebihara2, Osamu Kano1
1Department of Neurology, Toho University Faculty of Medicine, Tokyo, Japan.
Geriatrics & Gerontology International
|March 4, 2022
Summary
Parkinson's disease and frailty share symptoms and affect each other, particularly in older adults. Understanding their complex relationship is crucial for managing geriatric syndromes and improving quality of life.
Area of Science:
- Gerontology
- Neurology
- Geriatric Medicine
Background:
- Parkinson's disease is a progressive neurodegenerative disorder affecting motor and non-motor functions, with increasing global prevalence.
- Aging is a significant risk factor, exacerbating Parkinson's disease progression through various physiological changes.
- Frailty, a geriatric syndrome encompassing physical, psychological, and social aspects, is linked to sarcopenia and negatively impacts older adults' health.
Purpose of the Study:
- To elucidate the multifaceted relationship between Parkinson's disease and frailty.
- To explore the physical, mental, cognitive, and social dimensions of this association.
- To review existing literature on polypharmacy's role in frailty among Parkinson's disease patients.
Main Methods:
- This study is a narrative review of existing literature.
- It synthesizes information on the clinical features and mechanisms linking Parkinson's disease and frailty.
- The review examines aspects including physical, mental, cognitive, social, and polypharmacy issues.
Main Results:
- Both Parkinson's disease and frailty present overlapping symptoms and influence each other.
- The intricate interplay between aging, Parkinson's disease, and frailty requires further investigation.
- Limited research currently exists on the specific connections between Parkinson's disease and frailty.
Conclusions:
- Clarifying the relationship between Parkinson's disease and frailty is essential for comprehensive geriatric care.
- Addressing frailty, including sarcopenia and polypharmacy, is vital for maintaining the quality of life in older adults with Parkinson's disease.
- Further research is needed to fully understand the clinical features and underlying mechanisms of this dual diagnosis.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
791
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
791
Parkinson's Disease: Treatment
421
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
421
Neural Regulation
40.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.4K
Alzheimer's Disease: Overview
712
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
712
COPD: Pathogenesis and Clinical Features
659
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
659

